Heston WD - Search Results

1

Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.

Chan ES, Patel AR, Smith AK, Klein JB, Thomas AA, Heston WD, Larchian WA. Chan ES, et al. Among authors: heston wd. J Urol. 2009 Dec;182(6):2926-31. doi: 10.1016/j.juro.2009.08.020. Epub 2009 Oct 20. J Urol. 2009. PMID: 19846165

2

Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model.

Horinaga M, Harsch KM, Fukuyama R, Heston W, Larchian W. Horinaga M, et al. Urology. 2005 Aug;66(2):461-6. doi: 10.1016/j.urology.2005.03.052. Urology. 2005. PMID: 16040105

3

Mouse orthotopic models for bladder cancer research.

Chan E, Patel A, Heston W, Larchian W. Chan E, et al. BJU Int. 2009 Nov;104(9):1286-91. doi: 10.1111/j.1464-410X.2009.08577.x. Epub 2009 Apr 16. BJU Int. 2009. PMID: 19388981 Review.

4

Transabdominal micro-ultrasound imaging of bladder cancer in a mouse model: a validation study.

Patel AR, Chan ES, Hansel DE, Powell CT, Heston WD, Larchian WA. Patel AR, et al. Among authors: heston wd. Urology. 2010 Apr;75(4):799-804. doi: 10.1016/j.urology.2009.06.047. Epub 2009 Sep 20. Urology. 2010. PMID: 19773032

5

In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model.

Chan ES, Patel AR, Larchian WA, Heston WD. Chan ES, et al. Among authors: heston wd. J Urol. 2011 Jun;185(6):2359-65. doi: 10.1016/j.juro.2011.02.047. Epub 2011 Apr 21. J Urol. 2011. PMID: 21511281

6

Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model.

Chan ES, Patel AR, Hansel DE, Larchian WA, Heston WD. Chan ES, et al. Among authors: heston wd. Urology. 2012 Sep;80(3):736.e1-5. doi: 10.1016/j.urology.2012.04.038. Epub 2012 Jun 5. Urology. 2012. PMID: 22676953

7

Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer cells.

Horinaga M, Fukuyama R, Nishiyama T, Harsch KM, Cicek M, Heston W, Sizemore N, Casey G, Larchian W. Horinaga M, et al. Urology. 2005 Sep;66(3):676-81. doi: 10.1016/j.urology.2005.03.073. Urology. 2005. PMID: 16140114

8

Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study.

Laydner H, Huang SS, Heston WD, Autorino R, Wang X, Harsch KM, Magi-Galluzzi C, Isac W, Khanna R, Hu B, Escobar P, Chalikonda S, Rao PK, Haber GP, Kaouk JH, Stein RJ. Laydner H, et al. Among authors: heston wd. Urology. 2013 Feb;81(2):451-6. doi: 10.1016/j.urology.2012.02.075. Urology. 2013. PMID: 23374828

9

CD117⁺ cells in the circulation are predictive of advanced prostate cancer.

Kerr BA, Miocinovic R, Smith AK, West XZ, Watts KE, Alzayed AW, Klink JC, Mir MC, Sturey T, Hansel DE, Heston WD, Stephenson AJ, Klein EA, Byzova TV. Kerr BA, et al. Among authors: heston wd. Oncotarget. 2015 Jan 30;6(3):1889-97. doi: 10.18632/oncotarget.2796. Oncotarget. 2015. PMID: 25595903 Free PMC article.

10

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.

Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, Heston W, Kim I, Kim WJ, Koh GY. Yang H, et al. Mol Cancer. 2011 Apr 11;10:36. doi: 10.1186/1476-4598-10-36. Mol Cancer. 2011. PMID: 21481239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters